Frischer M, Leyland A, Cormack R, Goldberg D J, Bloor M, Green S T, Taylor A, Covell R, McKeganey N, Platt S
Communicable Diseases Unit, Ruchill Hospital, Glasgow, Scotland, United Kingdom.
Am J Epidemiol. 1993 Aug 1;138(3):170-81. doi: 10.1093/oxfordjournals.aje.a116843.
Although data on the prevalence of injection drug use are an essential prerequisite for estimating the number of individuals infected with the human immunodeficiency virus (HIV), there have been few attempts to utilize statistical methods of population estimation based on multiple data sources. Data on 3,670 cases (2,866 individuals) were obtained from the HIV test register, drug treatment agencies, police records, and needle and syringe exchanges in Glasgow, Scotland, in 1990. Log-linear analysis was used to model the number of individuals in each of the sources. The model incorporating dependency among the three health care agencies (HIV test, drug treatment, and needle exchange) and independence of the police sample fitted the data well, with a residual chi 2 value of 2.9 (6 df). The expected value of the missing cell corresponding to absence from all four samples was 5,628, yielding an overall estimate of 8,494 injectors (95% confidence interval (CI) 7,491-9,721), for a prevalence rate of 1.35% for people aged 15-55 years in Glasgow during 1990. The high ratio of known to unknown injectors (1:2) resulted from the extensive coverage of known injectors and the relatively high level of overlap between the combined health care agency sample and the police sample. While further analysis demonstrated that the probability of appearing in the four samples varied by age and sex, heterogeneity in the population did not affect the choice of model or substantially alter the estimates for the total number of unknown injectors. A concurrent study of a community-wide sample of 503 injectors resulted in an HIV prevalence rate of 1.1% (95% CI 0.4-2.5%). The results of these studies were combined to produce a further estimate of 93 HIV-infected current injectors in Glasgow (95% CI 33-214).
尽管注射吸毒流行率数据是估计感染人类免疫缺陷病毒(HIV)个体数量的重要前提,但很少有人尝试运用基于多种数据源的人口统计学估计方法。1990年,从苏格兰格拉斯哥的HIV检测登记处、戒毒治疗机构、警方记录以及针头和注射器交换处获取了3670例(2866名个体)的数据。采用对数线性分析对各数据源中的个体数量进行建模。包含三个医疗保健机构(HIV检测、戒毒治疗和针头交换)之间相关性以及警方样本独立性的模型与数据拟合良好,残差卡方值为2.9(自由度为6)。所有四个样本均未出现的缺失单元格的期望值为5628,由此得出格拉斯哥1990年15至55岁人群中注射吸毒者的总体估计数为8494人(95%置信区间(CI)7491 - 9721),流行率为1.35%。已知注射吸毒者与未知注射吸毒者的比例较高(1:2),这是由于已知注射吸毒者的广泛覆盖以及综合医疗保健机构样本与警方样本之间相对较高的重叠水平所致。进一步分析表明,出现在四个样本中的概率因年龄和性别而异,但人群的异质性并未影响模型的选择,也未对未知注射吸毒者总数的估计产生实质性改变。对503名注射吸毒者进行的社区范围同步研究得出HIV流行率为1.1%(95% CI 0.4 - 2.5%)。将这些研究结果结合起来,进一步估计格拉斯哥目前有93名感染HIV的注射吸毒者(95% CI 33 - 214)。